2 terminated, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Recruiting 1 |
Follow Cosyntropin: new trials by email Literature Review of Cosyntropin trials Research Report on Cosyntropin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy MNK-1411, Placebo - Muscular Dystrophy, Duchenne | Phase 2 | Terminated | Mallinckrodt ARD LLC | 44 | 2018-07-27 | 2021-03-16 |
| Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) Tetracosactide (Synacthène®), placebo saline (0.9% NaCl) - Post-dural Puncture Headache | Phase 2 | Terminated | Hospices Civils de Lyon | 46 | 2016-10-01 | 2025-08-08 |
| NeSST2: The Development of a Noninvasive Short Synacthen Test nasal Tetracosactide, IV tetracosactide - Adrenal Suppression | Phase 2 | Recruiting | Sheffield Children's NHS Foundation Trust | 12 | 2012-10-12 | 2024-12-03 |
Muscular Dystrophies (1) · Muscular Dystrophy, Duchenne (1) · Post-Dural Puncture Headache (1)
Hospices Civils de Lyon (1) · Mallinckrodt ARD LLC (1) · Sheffield Children's NHS Foundation Trust (1)
Bulgaria (1) · France (1) · Israel (1) · Italy (1) · Mexico (1) · Serbia (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Charlotte Elder (1)
2015 (1), 2017 (1)